HIGHLIGHTS
- who: Lawien Al Ali from the Department of Cardiology, University Medical Center Groningen, RB Groningen, the Netherlands have published the article: Predictors of adverse diastolic remodeling in non-diabetic patients presenting with ST-elevation myocardial infarction, in the Journal: (JOURNAL) of May/26,/2013
- what: The aim of this study was to identify the factors leading to diastolic remodeling. The research showed that metformin treatment, when compared to placebo, did not improve LV systolic or diastolic function at four months follow-up . The authors found that deterioration of diastolic function after STEMI is more pronounced . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.